The Last WeekAs we approach the final week of Replicel as a public company (assumed) there is little to no interest in buying $.02 shares to participate in this new private version of Replicel. What does that tell you ?
It tells me that the market and existing shareholders hold little hope of seeing a ROI in this moving forward.
Good luck to all the longs over the years....many have come and many have gone. A sad ending to this once promising company.